apollo
Banner
logo
0
Introducing Our Latest Arrival!
Femoston 0.5/2.5 mg Mini Tablet 28's

Femoston 0.5/2.5 mg Mini Tablet 28's

Prescription drug
 Trailing icon

Manufacturer/Marketer

Abbott India Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

About Femoston 0.5/2.5 mg Mini Tablet 28's

Femoston 0.5/2.5 mg Mini Tablet 28's is a hormone replacement therapy (HRT) used to treat postmenopausal symptoms and prevent osteoporosis (weak and brittle bones) caused by menopause in women. Post-menopause is a condition in which women have not had a period for 12 months or more. During menopause, estrogen levels decrease, leading to hot flushes (feeling of heat over the face, neck, and chest). Women with menopause are at risk of developing osteoporosis (thinning of bones). Femoston 0.5/2.5 mg Mini Tablet 28's can be used to prevent osteoporosis after menopause. Osteoporosis is a bone disease that weakens and thins bones by decreasing bone density which is common in post-menopausal women. 

Femoston 0.5/2.5 mg Mini Tablet 28's contains two female hormones, Estradiol and Dydrogesterone. Estradiol works by replacing the falling levels of estrogen in the body and thus helps to reduce menopause symptoms. Dydrogesterone works by reducing the overgrowth of the womb lining. Together, Femoston 0.5/2.5 mg Mini Tablet 28's helps treat postmenopausal symptoms and osteoporosis.

Femoston 0.5/2.5 mg Mini Tablet 28's should be taken as advised by your doctor. The dose of medicine and duration of treatment will be decided by the doctor based on your medical condition. Femoston 0.5/2.5 mg Mini Tablet 28's may cause certain side effects such as stomach pain, headache, breast pain or tenderness and back pain. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor. 

Femoston 0.5/2.5 mg Mini Tablet 28's should be avoided if you are allergic to it or if you have a history of breast cancer, endometrial cancer (cancer of the lining of the womb), unexplained vaginal bleeding, untreated endometrial hyperplasia (thickening of the womb lining), blood clotting disorder, heart attack or angina (chest pain), inherited porphyria (a blood disorder) or liver disease. It is not recommended for use in pregnant and breastfeeding women. Stop taking Femoston 0.5/2.5 mg Mini Tablet 28's and consult your doctor immediately if you develop jaundice (yellowing of the skin and eyes), high blood pressure and migraine-like headache, become pregnant or notice signs of a blood clot such as redness, swelling and pain in the legs, sudden chest pain or difficulty in breathing. Inform your doctor if you have any intolerance to sugar.

Uses of Femoston 0.5/2.5 mg Mini Tablet 28's

Treatment and prevention of hot flashes and osteoporosis in postmenopausal women

Medicinal Benefits

Femoston 0.5/2.5 mg Mini Tablet 28's contains Estradiol and Dydrogesterone used to treat postmenopausal symptoms and prevent osteoporosis (weak and brittle bones) caused by menopause in women. Estradiol restores the falling levels of estrogen in the body and thus helps to reduce menopause symptoms. Dydrogesterone decreases the overgrowth of the womb lining. Also, Femoston 0.5/2.5 mg Mini Tablet 28's is used as prophylaxis in preventing osteoporosis in postmenopausal women and prevents bone loss and fractures.

Directions for Use

Your doctor determines the dose of this medicine. Swallow it as a whole with a glass of water. Do not crush, chew or break it. Take this medication at a fixed time every day for better results.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Femoston 0.5/2.5 mg Mini Tablet 28's

  • Stomach pain

  • Headache

  • Breast pain or tenderness

  • Back pain

  • Changes in your menstrual periods

  • Nausea

Drug Warnings

Before starting treatment with Femoston 0.5/2.5 mg Mini Tablet 28's, inform your doctor if you are allergic to it. Avoid taking Femoston 0.5/2.5 mg Mini Tablet 28's if you are pregnant or breastfeeding. Femoston 0.5/2.5 mg Mini Tablet 28's is not recommended for children. If you have premature menopause, inform your doctor before taking Femoston 0.5/2.5 mg Mini Tablet 28's so that the risks and benefits may be compared. Avoid taking Femoston 0.5/2.5 mg Mini Tablet 28's if you have recently had a stroke, heart attack or angina (chest pain), liver disease and untreated endometrial hyperplasia (thickening of the womb lining). If you have very high levels of fat (triglycerides) in your blood, inform your doctor before taking Femoston 0.5/2.5 mg Mini Tablet 28's. You are recommended to avoid alcohol consumption with Femoston 0.5/2.5 mg Mini Tablet 28's as it may increase the risk of breast cancer. If you experience sudden chest pain, difficulty breathing, or painful swelling and redness of your legs, stop taking Femoston 0.5/2.5 mg Mini Tablet 28's and consult a doctor immediately, as these might be signs of a blood clot. Long-term use and high dosages of this medication may raise your risk of heart attack, stroke, blood clots, breast cancer, or uterine cancer. Hence discuss this risk with your doctor before taking Femoston 0.5/2.5 mg Mini Tablet 28's.

Drug Interactions

Drug-Drug Interactions: Femoston 0.5/2.5 mg Mini Tablet 28's may interact with anticonvulsants (phenytoin, carbamazepine, phenobarbital), antitubercular drugs (rifabutin, rifampicin), anti-HIV drugs (efavirenz, nelfinavir, ritonavir, nevirapine), painkiller (fentanyl), bronchodilator (theophylline) and immunosuppressants (cyclosporine, tacrolimus).

Drug-Food Interactions: Femoston 0.5/2.5 mg Mini Tablet 28's may interact with St. John’s wort (herbal medicine to treat depression). Also, avoid alcohol consumption, as it can lead to undesirable side effects.

Drug-Disease Interactions: If you have high blood pressure, gallstones, diabetes, migraine, epilepsy (fits), asthma, fluid retention due to kidney or heart problems, unexplained vaginal bleeding, breast cancer, liver disease, estrogen-sensitive cancer, porphyria, fibroids in the womb, endometrial hyperplasia (excessive thickening of the womb lining), blood clotting disorder or blood clot in the vein, inform your doctor before taking Femoston 0.5/2.5 mg Mini Tablet 28's.

Drug-Drug Interactions Checker List

  • PHENYTOIN
  • CARBAMAZEPINE
  • PHENOBARBITAL
  • RIFAMPICIN
  • EFAVIRENZ
  • RITONAVIR
  • FENTANYL
  • THEOPHYLLINE
  • CYCLOSPORINE

Habit Forming

No

Diet & Lifestyle Advise

  • Wear loose, layered clothing during the nighttime, especially in warm weather. This prevents hot flushes.

  • Manage your weight. Shed excess weight by exercising regularly if you are obese or overweight. 

  • Talk to a psychologist if you feel low, sad, isolated, or have sleeping issues.

  • Limit alcohol intake and quit smoking.

  • Try to eat foods that are rich in iron and Vitamin C, including red meat, shellfish, eggs, beans, and leafy green vegetables.

Special Advise

  • Regular breast screening is recommended while taking Femoston 0.5/2.5 mg Mini Tablet 28's.

  • Check your breasts regularly for any changes in the nipple, dimpling of the skin or any lumps.

  • While giving blood for tests, inform your doctor that you are taking Femoston 0.5/2.5 mg Mini Tablet 28's as this medicine may affect some test results. 

Disease/Condition Glossary

Post menopause: Menopause occurs when a woman is between 45 and 55 and has not had a period for 12 months or more. Post-menopause is a condition in which women have not had a period for 12 months or longer. The oestrogen levels decrease in postmenopausal women resulting in symptoms such as hot flushes (hot neck, face and chest).

Osteoporosis: It is a bone disease that weakens and thins bones by decreasing bone density.  As the density of bones decreases, they weaken and are more likely to break. Post-menopausal women are more likely to develop osteoporosis than men because, at menopause, a woman’s ovaries stop the production of oestrogen (a female hormone), which is essential to keep bones healthy. Following menopause, bone loss occurs, making bones weak and more likely to break. Signs and symptoms include back pain caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, and a bone that breaks much more easily than expected.

bannner image

Alcohol

Unsafe

Avoid consumption of alcohol with Femoston 0.5/2.5 mg Mini Tablet 28's as it may increase the risk of breast cancer and delay healing.

bannner image

Pregnancy

Unsafe

Femoston 0.5/2.5 mg Mini Tablet 28's is only recommended for postmenopausal women. Therefore, consult a doctor if you are pregnant.

bannner image

Breast Feeding

Unsafe

It is not recommended for use in breastfeeding. Hence, inform your doctor before taking Femoston 0.5/2.5 mg Mini Tablet 28's if you are breastfeeding. Your doctor may suggest you stop feeding while on treatment with this medicine.

bannner image

Driving

Safe

Femoston 0.5/2.5 mg Mini Tablet 28's may not affect your ability to drive.

bannner image

Liver

Unsafe

Femoston 0.5/2.5 mg Mini Tablet 28's should not be used in patients with liver diseases. Inform your doctor if you have/had a history of liver disease before starting treatment with this medicine.

bannner image

Kidney

Caution

Femoston 0.5/2.5 mg Mini Tablet 28's should be used with caution in patients with severe kidney diseases. Hence, if you have a pre-existing or a history of kidney disease, inform your doctor before taking Femoston 0.5/2.5 mg Mini Tablet 28's. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.

bannner image

Children

Unsafe

Femoston 0.5/2.5 mg Mini Tablet 28's is recommended for use in post-menopause women.

Country of origin

India

Manufacturer/Marketer address

401, Lsc, C-Block, Mohan Place Saraswati Vihar Delhi Dl 110034 In.
Other Info -

FAQs

Femoston 0.5/2.5 mg Mini Tablet 28's contains two female hormones, Estradiol and Dydrogesterone. Estradiol works by replacing the falling levels of estrogen in the body and thus helps to reduce menopause symptoms. Dydrogesterone works by reducing the overgrowth of the womb lining. Also, Femoston 0.5/2.5 mg Mini Tablet 28's is used as prophylaxis in preventing postmenopausal osteoporosis.
Femoston 0.5/2.5 mg Mini Tablet 28's is not a contraceptive. Femoston 0.5/2.5 mg Mini Tablet 28's is a hormone replacement therapy. Therefore, if you are less than 50 years old or if it is less than 12 months since your last period, you are advised to use additional contraceptive measures to avoid pregnancy. However, discuss with a doctor if you have any concerns regarding this.
Femoston 0.5/2.5 mg Mini Tablet 28's may cause irregular bleeding or spotting (drops of blood) during the first 3 to 6 months of taking Femoston 0.5/2.5 mg Mini Tablet 28's. However, if the bleeding or spotting continues for more than six months or after discontinuing Femoston 0.5/2.5 mg Mini Tablet 28's, please consult a doctor immediately.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Add to Cart